Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment

Beran, David Henri; Ewen, Margaret; Lipska, Kasia; Hirsch, Irl B.; Yudkin, John S.

doi:10.1007/s11892-018-1019-z

Scientific article

Review

English

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment

ContributorsBeran, David Henri

; Ewen, Margaret; Lipska, Kasia; Hirsch, Irl B.; Yudkin, John S.

Published inCurrent Diabetes Reports, vol. 18, no. 8, 48

Publication date2018

Abstract

The purpose of this review is to highlight the key issues with regard to the value, affordability, and availability of diabetes treatments.

Keywords

Diabetes
Health care costs
Health expenditure
Hypoglycemic agents
Insulin

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires

Citation (ISO format)

BERAN, David Henri et al. Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment. In: Current Diabetes Reports, 2018, vol. 18, n° 8, p. 48. doi: 10.1007/s11892-018-1019-z

Article (Published version)

Identifiers

PID : unige:144266
DOI : 10.1007/s11892-018-1019-z
PMID : 29907884

Additional URL for this publicationhttp://link.springer.com/10.1007/s11892-018-1019-z

Journal ISSN1534-4827

290views

1downloads

Creation12/10/2020 23:13:00

First validation12/10/2020 23:13:00

Update15/03/2023 22:59:22

Status update15/03/2023 22:59:21

Last indexation31/10/2024 20:15:10

Archive ouverte UNIGE

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment

The purpose of this review is to highlight the key issues with regard to the value, affordability, and availability of diabetes treatments.

Technical informations